Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Gracell Initiates Investigational Study of the Technological Breakthrough TruUCAR™ Therapy for Relapsed or Refractory T-cell Malignancies

prnasiaJanuary 09, 2020

Tag: Gracell , Investigational Study , Technological Breakthrough TruUCAR™ Therapy

PharmaSources Customer Service